Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: Gap junction protein α 1, 43kDa (GJA1; CX43; connexin-43); protocadherin 7 (PCDH7)

June 2, 2016 7:00 AM UTC

Patient sample and mouse studies suggest inhibiting GJA1 or PCDH7 could help treat brain metastases of breast cancer, NSCLC and other solid tumor types. In 189 triple-negative breast cancer (TNBC) pat...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article